We are live on ! Find out more
SBL

Sargent Bickham Lagudis Portfolio holdings

AUM $1.22B
1-Year Est. Return 14.94%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
-14.94%
3 Year Est. Return
+19.11%
5 Year Est. Return
+40.37%
10 Year Est. Return
AUM
$995M
AUM Growth
+$62.5M
Cap. Flow
+$1.04M
Cap. Flow %
0.1%
Top 10 Hldgs %
45.82%
Holding
859
New
55
Increased
172
Reduced
168
Closed
35

Sector Composition

Rank Sector Weight
1 Technology 6.06%
2 Healthcare 6.05%
3 Consumer Discretionary 4.74%
4 Financials 4.67%
5 Communication Services 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALB icon
626
Albemarle
ALB
$13.9B
$7K ﹤0.01%
80
AWR icon
627
American States Water
AWR
$3.36B
$7K ﹤0.01%
100
GGG icon
628
Graco
GGG
$12.9B
$7K ﹤0.01%
112
IUSB icon
629
iShares Core Universal USD Bond ETF
IUSB
$42.9B
$7K ﹤0.01%
128
+1
+0.8% +$55
SPCE icon
630
Virgin Galactic
SPCE
$328M
$7K ﹤0.01%
19
+3
+19% +$1.14K
UBX
631
DELISTED
Unity Biotechnology
UBX
$7K ﹤0.01%
200
USCI icon
632
US Commodity Index
USCI
$369M
$7K ﹤0.01%
220
VBR icon
633
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$7K ﹤0.01%
65
AMAT icon
634
Applied Materials
AMAT
$403B
$6K ﹤0.01%
+105
New +$6.49K
BLUE
635
DELISTED
bluebird bio
BLUE
$6K ﹤0.01%
9
CC icon
636
Chemours
CC
$2.5B
$6K ﹤0.01%
274
+2
+0.7% +$39
CME icon
637
CME Group
CME
$96.3B
$6K ﹤0.01%
37
DBAW icon
638
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$287M
$6K ﹤0.01%
228
+2
+0.9% +$55
DGRO icon
639
iShares Core Dividend Growth ETF
DGRO
$42.7B
$6K ﹤0.01%
155
+1
+0.6% +$40
DNLI icon
640
Denali Therapeutics
DNLI
$3.65B
$6K ﹤0.01%
165
-22
-12% -$663
DXC icon
641
DXC Technology
DXC
$1.82B
$6K ﹤0.01%
318
-2
-0.6% -$36
EDIT icon
642
Editas Medicine
EDIT
$396M
$6K ﹤0.01%
+200
New +$6.51K
EXPE icon
643
Expedia Group
EXPE
$35.4B
$6K ﹤0.01%
67
FBIN icon
644
Fortune Brands Innovations
FBIN
$5.88B
$6K ﹤0.01%
81
B
645
Barrick Mining
B
$61.5B
$6K ﹤0.01%
+200
New +$5.7K
GUNR icon
646
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.23B
$6K ﹤0.01%
213
+2
+0.9% +$58
INO icon
647
Inovio Pharmaceuticals
INO
$55.7M
$6K ﹤0.01%
44
KBE icon
648
State Street SPDR S&P Bank ETF
KBE
$1.64B
$6K ﹤0.01%
208
NIO icon
649
NIO
NIO
$12.2B
$6K ﹤0.01%
264
OGS icon
650
ONE Gas
OGS
$4.87B
$6K ﹤0.01%
83

Similar funds

Sargent Bickham Lagudis's Q3 2020 Portfolio in Review

As of Q3 2020, Sargent Bickham Lagudis held 859 positions worth $995M, up 6.7% from $933M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sargent Bickham Lagudis's Q3 2020 filing shows 55 new, 172 increased, 168 reduced and 35 closed positions. Its largest new stake was Invesco BulletShares 2027 Corporate Bond ETF: 23,266 shares worth $511K. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $16.2M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Sargent Bickham Lagudis's largest Q3 2020 buy was Invesco BulletShares 2027 Corporate Bond ETF: 23,266 shares worth $511K.
  • Sargent Bickham Lagudis added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $25.6M increase.
  • Sargent Bickham Lagudis's biggest Q3 2020 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $16.2M.
  • Sargent Bickham Lagudis fully exited State Street Energy Select Sector SPDR ETF in Q3 2020, selling an estimated $944K.
  • Sargent Bickham Lagudis's ten largest holdings make up 46% of its $995M portfolio in Q3 2020.
  • Sargent Bickham Lagudis opened 55 new positions and closed 35 in Q3 2020.
  • Sargent Bickham Lagudis's portfolio value rose 6.7% quarter-over-quarter to $995M.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2020, filed 1 Sep 2021.